日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel.

使用 FLT PET/CT 对采用 X-82 和多西他赛序贯联合治疗的晚期实体恶性肿瘤进行药效学研究

Scarpelli Matthew, Rampurwala Murtuza, Eickhoff Jens, Carmichael Lakeesha, Heideman Jennifer, Binger Kimberly, Kolesar Jill, Perlman Scott, Harrow Kim, Dukart Gary, Liang Chris, Jeraj Robert, Liu Glenn, Bruce Justine Yang

A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies

一项针对肾细胞癌和其他晚期实体恶性肿瘤患者的舒尼替尼联合贝伐单抗序贯治疗的I期药效学试验

Bruce, Justine Yang; Kolesar, Jill M; Hammers, Hans; Stein, Mark N; Carmichael, Lakeesha; Eickhoff, Jens; Johnston, Susan A; Binger, Kimberly A; Heideman, Jennifer L; Perlman, Scott B; Jeraj, Robert; Liu, Glenn